This brand name is authorized in Nigeria.
The drug ANGITEL contains one active pharmaceutical ingredient (API):
1
|
UNII
U5SYW473RQ - TELMISARTAN
|
|
Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-9718 | Tablet | Angitel 40 Tablets TAB 40 mg 3 x 10's (in Alu-Alu blisters) | Uncoated tablets ANGITEL 40 TABLETS TELMISARTAN USP 40MG Telmisartan USP 40MG (EXCIPIENTS: Mannitol 45mg, Meglumine 32mg, Iso Propyl Alcohol 85mg, Kyron (T-314) 19mg, Microcrystalline cellulose (pH 102) 13mg, Colloidal anhydrous silica 2mg, Croscarmellose sodium 10mg, Purified talc 2mg, Sodium stearyl fumarate 4mg) B4-9718 Drugs VARIOUS Imported Products 3X10TABLETS POM 1 08/04/2024 ZIFAM PINNACLE NIGERIA LTD, ILUPEJU BYPASS BESIDE FIRST BANK ILUPEJU MUSHIN LAGOS 1867188 zifamnigeria@gmail.com FREDUN PHARMACEUTICALS LTD., 14, 15, 16, ZORABIAN INDUSTRIAL COMPLEX, VILLAGE VEOOR, PALGHAR, DIST. THANE 401404. INDIA., India | 30/01/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C09CA07 | Telmisartan | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-9572, B4-9718 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.